GO
Loading...

Pfizer Inc

More

  • Final Glance: Pharmaceuticals companies Thursday, 31 Jul 2014 | 6:04 PM ET

    Baxter International Inc. fell $1.40 or 1.8 percent, to $74.69. Bristol-Myers Squibb Co. fell$. 50 or 1.0 percent, to $50.62. Hospira fell$. 74 or 1.3 percent, to $55.47.

  • Most active New York Stock Exchange-traded stocks Thursday, 31 Jul 2014 | 1:33 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AT&T Inc. fell 2.1 percent to $35.59 with 33,017,900 shares traded. Advanced Micro Devices Inc. rose 2.4 percent to $3.91 with 111,865,000 shares traded.

  • AstraZeneca steps up push into cancer immunotherapy Thursday, 31 Jul 2014 | 8:51 AM ET

    LONDON, July 31- AstraZeneca is accelerating its push into cancer immunotherapy, with plans to test a key experimental drug in new tumor types. AstraZeneca said it would present further data looking at MEDI4736 in lung cancer, as well as early results for head and neck cancer, in September at the annual meeting of the European Society for Medical Oncology.

  • *Investors focused on possible Pfizer return. LONDON, July 31- AstraZeneca raised its sales and earnings forecasts for the year on Thursday, showing resilience after seeing off a $118 billion takeover approach from rival Pfizer two months ago.

  • LONDON, July 31- AstraZeneca smashed forecasts for second-quarter sales and earnings on Thursday, demonstrating resilience after seeing off a $118 billion takeover approach from rival drugmaker Pfizer two months ago.

  • LONDON, July 31- AstraZeneca smashed forecasts for second-quarter sales and earnings on Thursday, demonstrating resilience after seeing off a $118 billion takeover approach from rival drugmaker Pfizer two months ago.

  • Final Glance: Pharmaceuticals companies Wednesday, 30 Jul 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 25 or. 3 percent, to $76.09. Bristol-Myers Squibb Co. rose$. 11 or. 2 percent, to $51.12. Hospira rose $4.31 or 8.3 percent, to $56.21.

  • Most active New York Stock Exchange-traded stocks Wednesday, 30 Jul 2014 | 1:22 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. Advanced Micro Devices Inc. rose. 8 percent to $3.82 with 42,461,500 shares traded. Bank of America Corp. rose 1.6 percent to $15.58 with 80,663,400 shares traded.

  • Midday Glance: Pharmaceuticals companies Wednesday, 30 Jul 2014 | 1:22 PM ET

    Baxter International Inc. rose$. 07 or. 1 percent, to $76.41. Bristol-Myers Squibb Co. fell$. 03 or. 1 percent, to $50.98. Hospira rose $4.08 or 7.9 percent, to $55.98.

  • Pfizer buying two Baxter vaccines for $635M Wednesday, 30 Jul 2014 | 12:39 PM ET

    NEW YORK— Pfizer will spend $635 million on two vaccines owned by Baxter International that are sold in a number of European countries and other locations outside of the U.S. Pfizer will also get part of a manufacturing facility in Australia as part of the purchase. Pfizer stock fell 29 cents to $29.18 in midday trading.

  • Early Glance: Pharmaceuticals companies Wednesday, 30 Jul 2014 | 10:42 AM ET

    Baxter International Inc. rose$. 54 or. 7 percent, to $76.88. Bristol-Myers Squibb Co. fell$. 29 or. 6 percent, to $50.73. Hospira rose $2.11 or 4.1 percent, to $54.01.

  • DUBLIN, July 30- Ireland is in the firing line from Washington again for luring U.S. companies to its shores for tax benefits, but despite contrite noises coming from Dublin, it has too much to lose to discourage U.S. firms bent on shifting their tax domiciles.

  • *Sanofi to file drug for US and EU approval by year-end. PARIS, July 30- A new drug being developed by French drugmaker Sanofi and U.S. partner Regeneron cut "bad" LDL cholesterol more than placebo and existing treatments in nine late-stage clinical trials, the companies said on Wednesday.

  • LONDON, July 30- AstraZeneca took a major step to build up its respiratory medicine business on Wednesday by striking a deal worth up to $2.1 billion to acquire the rights to lung drugs developed by Spain's Almirall.

  • AstraZeneca announces Almirall deal worth up to $2.1B Wednesday, 30 Jul 2014 | 2:24 AM ET

    AstraZeneca took steps to build up its respiratory medicine business by striking a deal to acquire the rights to lung drugs developed by Almirall.

  • LONDON, July 30- AstraZeneca took a major step to build up its respiratory medicine business on Wednesday by striking a deal worth up to $2.1 billion to acquire the rights to lung drugs developed by Spain's Almirall.

  • *Merck up as results beat expectations, but Pfizer slips. United Parcel Service shares fell 3.7 percent to $98.86 after the world's biggest courier company slashed its earnings forecast for the year due to spending to boost capacity. Rival shipping company FedEx Corp was down 1.6 percent at $147.14.

  • Stocks fall; Ukraine concerns overtake earnings cheer Tuesday, 29 Jul 2014 | 4:17 PM ET
    Traders work on the floor of the New York Stock Exchange (NYSE) on Friday.

    Stocks fell Tuesday as geopolitical issues came back into play, offsetting upbeat earnings.

  • *Merck up as results beat expectations, but Pfizer slips. United Parcel Service shares fell 3.1 percent to $99.47 after the world's biggest courier company slashed its earnings forecast for the year due to spending to boost capacity. Rival shipping company FedEx Corp was down 0.8 percent at $148.36.

  • AP Top Financial News At 2:15 p.m. EDT Tuesday, 29 Jul 2014 | 2:15 PM ET

    Fed is weighing key issues but may reveal little Stocks inch up ahead of economic data US consumer confidence jumps to 90.9 in July Avoiding plane crashes as air traffic doubles Sources: EU adopts tough new sanctions on Russia Study: 35 percent in US facing debt collectors UBS sees profits rise, probed over trading system China investigating Microsoft in monopoly case US home price gains slow for 6th straight month Pfizer's 2 Q profit sinks 79 pct but tops forecasts